Skip to main content
Clinical Trials/CTRI/2025/03/082732
CTRI/2025/03/082732
Not yet recruiting
Phase 2

A randomised controlled clinical trial to evaluate the efficacy of Rasanjanadi Lepa in mangament Of Nadi Vrana (Pilonidal Sinus)

Dr Sarvagya Pathak1 site in 1 country172 target enrollmentStarted: March 24, 2025Last updated:

Overview

Phase
Phase 2
Status
Not yet recruiting
Sponsor
Dr Sarvagya Pathak
Enrollment
172
Locations
1
Primary Endpoint
Wound dimension

Overview

Brief Summary

This study is Randomised ,Parallel group, active controlled trial to evaluate the safety and efficacy of Rasanjanadi lepa, in 172 patient aged between 16 to 45 years , over a period of 18 months. The patient will be of 21 days . During the trial assessment will be done on 0th , 7th, 14th, 21th, 28th days . After trial , follow up will be done after 43rd , 58th, 73rd, & 88th day after cessation of procedure.

Study Design

Study Type
Interventional
Allocation
Randomized
Masking
None

Eligibility Criteria

Ages
16.00 Year(s) to 45.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • Age group of patient 16 to 45 years.
  • Patient diagnosed with Pilonidal Sinus & Abscess as per diagnostic criteria .
  • Patient capable of reading , completing, and assigning the consent from participating in the study.

Exclusion Criteria

  • Presenting with dry & hard ulcer Presenting with Vatadhik Lakshan pregnant and lactating women Addiction to drugs and alcohol Abnormal bleeding from the wound using drugs that affect wound healing such as corticosteroids Using antibiotics prior to surgical intervention Not continuing the proposed treatment until the end of the study or request to leave the study History of severe allergy or anaphylactic shock caused by similar treatment Patient who has undergone organ transpiration Known case of connective tissue disease Known allergies to herbal drugs.

Outcomes

Primary Outcomes

Wound dimension

Time Frame: 21 days

Depth of wound

Time Frame: 21 days

Wound excaudate quantity

Time Frame: 21 days

Improvement in other symptoms or Pilonidal Sinus

Time Frame: 21 days

Bacterial load by culture & sensitivity test

Time Frame: 21 days

CRP

Time Frame: 21 days

Time period

Time Frame: 21 days

Wound volumetry

Time Frame: 21 days

Secondary Outcomes

  • Improvement in other symptoms like pain(After analysing all the parameters the result will be assessed on the basis of symptomatic relief and improvement.)

Investigators

Sponsor
Dr Sarvagya Pathak
Sponsor Class
Other [Dr.Sarvagya Pathak]
Responsible Party
Principal Investigator
Principal Investigator

Dr Sarvagya Pathak

Kunwar Shekhar Vijendra Ayurved Medical College and Research Centre , Gangoh-247341.

Study Sites (1)

Loading locations...

Similar Trials